Price $45.13 |
Market Cap
1B
|
Sector Health Care |
Div. Growth
15.80%
|
|
P/E
36.1
|
P/B
3.82
|
P/S
6.24
|
Dividend %
1.10%
|
|
P/CF
-
|
P/FCF
49.7
|
Op. Cash Flow
33.7K
|
FCF
0.9
|
|
Op. Margin
23.10%
|
Net Margin
17.10%
|
ROE
11.40%
|
ROI
11.40%
|
|
ROA
9.60%
|
EPS Growth
7.10%
|
Current Ratio
6.4
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Psychemedics Corp. (PMD) | $6.29 | - | 4.50% | 35.3M | Strong Buy |
| Clearside Biomedical Inc (CLSD) | $1.65 | - | - | 78.2M | Strong Buy |
| Repro-Med Systems, Inc. (KRMD) | $2.43 | - | - | 98.3M | Strong Buy |
| Chembio Diagnostics Inc (CEMI) | $0.65 | - | - | 22.7M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $3.82 | - | - | 150.9M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
